STAT+: Pharmalittle: Europe looks to sue AstraZeneca over Covid-19 vaccine shortfalls; FDA skewers Emergent vaccine facility
Hello, everyone, and how are you today? Cold winds are whipping about the Pharmalot campus,…
Category: Pharma
STAT+: FDA issues scathing report of Emergent plant responsible for contaminated Covid-19 vaccines
The Food and Drug Administration issued a scathing inspection report of the Emergent BioSolutions (EBS)…
STAT+: Pharmalittle: Pfizer identifies first counterfeit versions of its Covid-19 vaccine; top house Democrats investigate Emergent BioSolutions
Rise and shine, everyone, another busy day is on the way. This is the middle…
Most Americans say they should be vaccinated before the U.S. donates Covid-19 shots elsewhere
Three-quarters of Americans believe the U.S. government should start donating Covid-19 vaccines to other countries,…
STAT+: Congress probes Emergent’s ties to a key Trump official in wake of Covid-19 vaccine scandal
A pair of top House Democrats is investigating whether Emergent BioSolutions (EBS), which was responsible…
STAT+: Pfizer shareholders are urged to reject political spending that contradicts ‘company values’
Arguing that Pfizer’s political spending conflicts with the company’s publicly stated values, a philanthropic organization…
STAT+: Pharmalittle: Biden aides met with U.S. health companies about supply chains; J&J Covid-19 shot notched $100m in sales
Hello, everyone, and how are you today? A shiny sun and delightful breeze are enveloping…
STAT+: Pharmalittle: J&J denies design of its Covid-19 shot may explain blood clots; second trial against opioid makers begins
Good morning, everyone, and welcome to another working week. Once again, another delightful weekend respite…
STAT+: Advocacy groups outraged after PBM offers a $500 gift card to persuade patients to switch drugs
Dozens of patient advocacy groups are angry over an unusual move by a pharmacy benefits…
STAT+: Pharmalittle: J&J rivals rebuff bid to jointly study Covid-19 vaccine risks; will next-gen Covid shots be better or worse?
And so, another working week will soon draw to a close. Not a moment too…
STAT+: A drug maker sues a medical journal, its editor, and several authors for libel
In an unusual move, Pacira Biosciences (PCRX) has filed a libel lawsuit against a medical…
STAT+: Thermo Fisher buys contract-research company PPD for $17.4 billion
Thermo Fisher Scientific announced Thursday that it will buy PPD, a contract-research company for the…
.jpg)
STAT+: WTO head urges movement on controversial Covid-19 vaccine proposal, but objections remain
Amid mounting pressure to widen global access to Covid-19 vaccines, the head of the World…
STAT+: Pharmalittle: Pause for J&J Covid-19 shot to continue at least a week; Biden expands candidate list for FDA commish
Top of the morning to you. Gray skies are hovering over the Pharmalot campus right…
STAT+: WHO warns the world is still failing to develop desperately needed antibiotics
Despite mounting concern over antibiotic resistance, a new report finds that none of 43 antibiotics…
STAT+: FDA is urged to move faster to list medicines withdrawn over safety concerns
Arguing patient safety is at risk, an advocacy group is urging the Food and Drug…
STAT+: Pharmalittle: Pfizer to boost Covid-19 vaccine production for the U.S.; J&J faces new test with Covid-shot pause
Hello, everyone, and welcome to the middle of the week. You made it this far,…
STAT+: A U.S. appeals court upholds the FTC view of controversial pay-to-delay settlements
In what is being called a win for consumers, a U.S. appeals court upheld a…
STAT+: Pharmalittle: U.S. urges states to pause J&J Covid-19 shots; PhRMA’s new message says ‘Don’t take us for granted’
Rise and shine, another busy day is on the way. However, this is also shaping…
STAT+: Europe tries to lower drug prices with small doses of transparency
For countries in Europe, negotiating a deal with a pharma company over drug prices is…
STAT+: Federal agency says pharma should pay higher Medicaid rebates if certain trials aren’t finished on time
In a bid to lower prescription drug costs, a federal agency is recommending pharmaceutical companies…
STAT+: Pharmalittle: Regeneron antibody reduced Covid-19 infection risk; variant first seen in South Africa can somewhat ‘break through’ Pfizer shot
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
Opinion: STAT+: Three steps toward creating a functioning U.S. biosimilars market
The development of safe, effective, and innovative biologic medicines is one of modern medicine’s far-reaching…
STAT+: Clinical study reports hold more details about the side effects of cancer drugs
For years, researchers have urged regulators to release clinical study reports that are generated during…
STAT+: Pharmalittle: Lilly arthritis drug failed main goal in Covid-19 study; Serum Institute asks India for a big grant to make Covid shots
And so, another working week will soon draw to a close. Not a moment too…
STAT+: Brazilian judge temporarily suspends pharmaceutical patent extensions amid push to lower drug costs
A Brazilian Supreme Court judge suspended extensions for pharmaceutical patents in the country, and although…
STAT+: Pharmalittle: EMA finds link between AstraZeneca shot and rare blood clots; life science private financing is at record levels
Rise and shine, another busy day is on the way. However, this is also shaping…
Judge rules Purdue must answer questions about documents showing any link between OxyContin, birth defects
A federal judge has given a green light to lawyers representing children with birth defects…
.jpg)
STAT+: Merck reaches deal with Austrian antitrust regulators over ‘predatory’ pricing for a cancer drug
Following a three-year probe, Merck (MRK) reached a deal with Austrian regulators to end a…
STAT+: Pharmalittle: U.S. is prohibited from sharing Covid-19 shots with other countries; U.S. officials knew of problems at Emergent plant
Good morning, everyone, and how are you today? We are doing just fine, thank you,…
STAT+: A controversial court case in Brazil will tackle pharma ‘monopolies’ and access to drugs
After years of anticipation, the Brazilian Supreme Court is holding a hearing this week on…
STAT+: California once again delays launch of a closely watched prescription drug purchasing program
For the second time this year, California officials have delayed a much-ballyhooed effort to start…
STAT+: Pharmalittle: EMA official says link exists between AstraZeneca Covid-19 shot and rare blood clots; Catalent to boost Moderna vaccine production
Top of the morning, and a fine one it is. Clear blue skies and a…
STAT+: Lilly is a holdout among companies that agree to disclose when executive pay is clawed back
A coalition of institutional investors is pushing Eli Lilly to adopt a policy to disclose…
STAT+: Pharmalittle: U.S. puts J&J in charge of plant that botched Covid-19 vaccines; pharmacies offering Covid shots raise privacy concerns
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
STAT+: Bristol Myers agrees to pay $75 million to settle allegations of underpaying Medicaid rebates
After years of litigation, Bristol-Myers Squibb (BMY) agreed to pay $75 million, plus interest, to…
STAT+: Pharmalittle: FDA is probing J&J Covid-19 vaccine blunder; Fauci says U.S. may not need the AstraZeneca shot
And so, another working week will soon draw to a close. Not a moment too…
STAT+: FDA is rebuked by a federal agency for downgrading serious concerns over plant inspections
In a stern letter, the U.S. Office of Special Counsel rebuked the Food and Drug…
STAT+: Pharmalittle: 15 million doses of J&J Covid-19 vaccine ruined by ‘human error’; Bristol Myers fights U.S. over a $1.4 billion tax bill
Top of the morning to you. A spot of rain is descending on the Pharmalot…
STAT+: The U.S. government doesn’t have patent rights to Gilead’s remdesivir, despite investing millions in research
American taxpayers may have provided $162 million toward researching the drug remdesivir, but the federal…
STAT+: Pharmalittle: Pfizer says Covid-19 shot is safe and effective in adolescents; FTC wants to block another Illumina deal
Good morning, everyone, and how are you today? We are doing just fine, thank you,…
STAT+: FTC seeks to block Illumina from buying Grail, citing threats to competition
The Federal Trade Commission is once again trying to block Illumina, a dominant maker of…
STAT+: Most U.S. universities get an ‘F’ on ensuring access to drugs they discover
Despite large amounts of taxpayer funding, dozens of the largest U.S. universities failed to commit…
STAT+: Pharmalittle: Pfizer and BioNTech to boost Covid-19 vaccine production; lawmakers ask FTC to probe insulin pricing
Rise and shine, another busy day is on the way. There is a rhythm to…
STAT+: Canadian company pursues compulsory license to distribute Covid-19 vaccine to low-income countries
Twice in recent months, a small Canadian company has approached two large drug makers to…
STAT+: Congressional lawmakers urge FTC to investigate insulin makers over their pricing
In the latest flare up over the cost of insulin, several Congressional lawmakers want the…
STAT+: Pharmalittle: White House eyes suspending patent rights on Covid-19 vaccines; J&J supplier may be a vaccine bottleneck
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
STAT+: Former top Lilly lobbyist sues the company for alleged sex discrimination and harassment
A former top lobbyist at Eli Lilly (LLY) has filed a lawsuit accusing an executive…
Opinion: Money from opioid lawsuits is urgently needed now
Opioid companies are being forced to pay for their grave mistakes and misdeeds in helping…
STAT+: Canada says drug spending keeps rising due to increasingly expensive specialty meds
As Canadians brace for new rules to address prescription drug spending, a government report found…